Covid19

Intranasal COVID-19 vaccine candidate generates robust immune response – Healio

BOSTON — Two doses of an experimental live-attenuated intranasal COVID-19 vaccine generated a robust immune response, according to phase one data …

Read more at www.healio.com

Show More

Related Articles

Back to top button